Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

Stevanato Group S.p.A.

Stevanato Group specializes in integrated solutions for the Pharmaceutical and Healthcare industry, providing systems, processes, and services.

NYSE:STVN

Stevanato Group

Last Close

22.72

08/11 21:00

Market Cap

5.36B

Beta: -

Volume Today

759.25K

Avg: 283.80K

PE Ratio

56.83

PFCF: −62.50

Dividend Yield

0.18%

Payout:9,065.64%